Clinical trial
Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection
NCT00180674 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00180674 |
|---|---|
| Title | Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection |
| Official title | Anticoagulation for Liver Fibrosis in Patients With Hepatitis C Virus Infection: Pilot Study |
| Lead sponsor | Imperial College London, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Fibrosis |
| Intervention type | Drug |
| Interventions | Warfarin |
| Enrollment | 14 |
| Start date | Aug 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 1, 2020 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: